Reporting of overall immediate breast reconstruction and of racial disparities varies significantly between SEER and 2 large US databases.
No greater risk of complications for older patients; benefited as much as younger breast cancer patients
A Systematic Review and Meta-analysis of Harmonic Technology Compared With Conventional Techniques in Mastectomy and Breast-conserving Surgery With Lymphadenectomy for Breast CancerSeptember 01, 2016
[Breast Cancer: Targets and Therapy] This research compares Harmonic technology and conventional techniques for a range of clinical outcomes and complications in both mastectomy and BCS patients, including axillary lymph node dissection.
Consensus guideline states that a 2 mm margin is enough to guard against recurrences while reducing need for additional operations for women with DCIS who undergo breast-conserving surgery.
Comprehensive patient education that includes information on breast reconstruction, with photos, can help women with breast cancer make more informed decisions about their treatment options.
In women undergoing postmastectomy breast reconstruction with their own tissue, a specific type of muscle-sparing abdominal tissue reduced complications and improved some aspects of quality of life.
Fat Injection for Postmastectomy Breast Reconstruction Does Not Increase Risk of Recurrent Breast CancerFebruary 17, 2016
The use of lipofilling for postmastectomy breast reconstruction does not increase the risk of recurrent breast cancer. These findings are from an analysis of a plastic surgery database.
Travel distances continue to be a significant barrier to women undergoing breast reconstruction after mastectomy for breast cancer.
A revolutionary alternative to radical mastectomy has been developed that preserves the nipple, areola, and surrounding skin.
Single-stage implant procedures after mastectomy may be a good option for selected patients.
Research indicates that women who undergone mastectomy have greater satisfaction when breast reconstruction is performed using the patient's own tissues, rather than implants.
For women undergoing breast reconstruction, autologous reconstruction leads to higher satisfaction than alloplastic reconstruction, but secondary correction is often required.
Following a mastectomy, less than 42% of women underwent breast reconstruction, and the factors associated with foregoing reconstruction included being black, being less educated, and being older.
A new mechanism has been reported by which BRCA gene loss may accelerate cancer-promoting chromosome rearrangements.
A new study finds that the majority of women who undergo mastectomy for breast cancer go on to get breast reconstruction, a practice that has increased dramatically over time.
Use of breast reconstruction in women undergoing mastectomy for breast cancer increased significantly, from 46% in 1998 to 63% in 2007.
Factors such as smoking and obesity increase the odds of early implant loss in women who undergo mastectomy and immediate breast reconstruction with implants.
Women who have received cosmetic breast implants may have an increased risk of diagnosis at a non-localized stage of breast cancer, and seem to have worse breast cancer survival.
For women undergoing breast reconstruction with implants, most patient-reported outcomes are similar with two different types of silicone gel-filled implants.
Breast cancer patients who undergo a mastectomy followed by breast reconstruction using a transplanted flap of their own tissue have a low rate of early postoperative complications. However, a new study found that their risk varies by the type of flap procedure they undergo.
Seroma complications are higher with AlloDerm human matrix than porcine Strattice.
Enhanced stromal vascular fraction and platelet-rich plasma grafting maintain volume, 3D contour.
Radiation therapy slightly improves survival, but may increase likelihood of eventual mastectomy.
CAD/CAM are extending their reach from industrial and engineering pursuits into the patient care arena, with the technology now being used to aid in breast reconstruction for people with cancer.
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Including a PI3-Kinase Inhibitor with an PARP Inhibitor Improves Tumor Shrinkage in Patients with Resistant Ovarian Cancer
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Primary Care Physicians Surveyed on Breast Cancer Screening Practices
- Low Acculturated Latina Women Reported Breast Cancer Treatment Experience Differently Than Other Groups
- Cost and Complication Rates Differ Among Early Breast Cancer Treatment Options
- Distress Management Tool Gets an Update, Patient Version
- PSA Screening Rates Level Off in United States
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|